Pharma behaving well?
From Evidence In Medicine
February 6, 2012 - 10:28pm
We have known for many years now that patients having an acute coronary syndrome (ACS) do better if they are immediately treated with aspirin, and that they do even better if in addition to that single antiplatelet agent they are also treated with clopidogrel. In 2009, the PLATO trial was published in the NEJM. It was a randomized trial in more than 18,000 people having an ACS, comparing the benefits of adding either clopidogrel or the newer agent ticagrelor to aspirin. Ticagrelor appeared to cause some increased serious bleeding, but overall it reduced a composite endpoint of vascular death, MI,...
February 6, 2012 - 10:28pm
Share This Article:
Pharma Buzz
- Jun19 8:04pmGlobal Problems, New Ideas
- Jun19 7:00pmCFDA Orders Hong Kong Suspension Of Cold Pill To Test For Banned Drug
- Jun19 6:55pmRanbaxy Hit By EU Pay-For-Delay Fine Of $13.7 Million
- Jun19 6:50pmPfizer, Protalix In $280 Million Deal To Supply Brazil With Gaucher Drug
- Jun19 5:15pmANDA Stability Final Guidance Arrives, But Offers Few Answers for Industry
- Jun19 5:15pmANCHOR Indication For Amarin’s Vascepa Will Face FDA Panel Scrutiny
- Jun19 5:10pmGermany’s IQWiG Fells AstraZeneca’s Caprelsa Again, Proving Mortality Trumps All
- Jun19 5:00pmPlan B One-Step OTC Proposal Leaves Plaintiffs, Judge Korman Wary
- Jun19 5:00pmObesity Drugs Could Get Lift From Part D Legislation, AMA Policy
- Jun19 5:00pmNothing To SAVOR For Bristol/AZ From Phase IV Results
- Jun19 4:26pmYou Just Won... Lilly Fights Scam Artists Over Use Of Its Name
- Jun19 4:10pmNanotube Probe Gives a Single Neuron’s View of Brain Activity
- Jun19 3:02pmMr. Hassan May Choose His Opinions; But He Can't Choose His "Facts" -- Even A Decade On.
- Jun19 1:41pmThe Ethics of a Politician’s Speaking Fee
- Jun19 1:15pmU.K’s NICE To Help Build India’s Health Technology Assessment Board
- Jun19 1:06pmTotal Recall? China Chastises J&J Over Its Product Recall Policy
- Jun19 12:55pmSneak Preview: Clinical Trial Policies Top IP As Biggest Obstacle To Indian Innovation
- Jun19 12:45pmSurge In Partnerships And Licensing In China Highlights Need For Greater Flexibility
- Jun19 12:40pmGSK Negotiating Potential $1 Billion Sale Of Two Thrombosis Drugs To Aspen
- Jun19 12:28pmCould The US Save $200B By Using Medicines More Responsibly?
- Jun19 11:59amAMA's obesity ruling could inspire new drug efforts
- Jun19 11:56amTeva agrees to lift the veil on executive pay
- Jun19 11:44amChrysler Reverses Course and Agrees to Recall Older-Model Jeeps
- Jun19 11:35amTotal Access: YODA Gains Full Access to Clinical Trials Data
- Jun19 11:34amWhat we talk about when we talk (on LinkedIn) about pharma
- Jun19 11:31amNo More Secrets: Medtronic Shows How Open Science Might Work In The Real World
- Jun19 11:28amCompany offers simplified 3-prong approach to personalized nutrition
- Jun19 10:39amEurope adds to drugmakers' pain on pay-to-delay strategy
- Jun19 10:38amAffinity RNs Call for Halt to Flawed Electronic Medical Records System Scheduled to Go Live Friday
- Jun19 10:24amBiogen's impressive Tecfidera launch hits reimbursement, supply snags
- Jun19 10:23am"Computer problems" force docs back to paper charts at Memorial Hospital - From June 11 until at least June 24?
- Jun19 10:04amA Bristol-Myers And AstraZeneca Diabetes Trial Is A 'Dud'
- Jun19 9:51amOnglyza fails outcomes trial in a $1B hit for Bristol-Myers, AstraZeneca
- Jun19 9:30amWhy I retracted my Nature paper: A guest post from David Vaux about correcting the scientific record
- Jun19 9:08amA Call to Restore the Integrity of Clinical Research - but Will Anyone Heed it?
- Jun19 8:56amHow Much? Teva Agrees To Disclose Executive Pay
- Jun19 8:00amUse prescription meds properly, save $200 billion a year
- Jun19 7:37amLundbeck Fined $125M Over Pay-To-Delay Deal In Europe
- Jun19 7:30amA Walk Around Primary Jurisdiction
- Jun19 7:30amWith a Top Secret Letter, HRSA Blesses Amgen’s New 340B Distribution Plan
- Jun19 7:17amThe Drug Industry and the Obama Administration
- Jun19 6:49amPfizer's Customer Approach: Change and Deliver
- Jun19 5:33amOnline Networks Like PatientsLikeMe Could be the Key to Clinical Trial Recruitment
- Jun19 4:16amPharmaguy EU Tour 2013 - The Infographic
- Jun19 2:35amJapan Ministry Still Puzzled By Adverse HPV Vaccine Reactions
- Jun19 2:30amBrazil Plans Own Making Of H1N1 Vaccine To Avoid Private-Sector Pitfalls
- Jun19 2:20amAspen Bids To Buy Thrombosis Drugs, Production Plant From GSK
- Jun19 1:35amThe trend of blocking URL's on ISP's continues in India?
- Jun19 1:00amWhat’s the No. 2 Cause of Accidental Death in Children?
- Jun19 1:00amSenator Durbin to Reintroduce Supplement Bill
